Get started
Author

Ram Jha

Observed names: Jha, Ram, R. Jha
ORCID: 0009-0001-8015-7782
Observed ORCID: 0009-0001-8015-7782
OpenAlex ID: A5055782950
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial
2021 · Shaun Cordoba, Shimobi Onuoha, et al. · Nature Medicine · 302
PDF
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial
2024 · Kate Cwynarski, Gloria Iacoboni, et al. · Nature Medicine · 52
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR
2023 · Evangelia Kokalaki, Biao Ma, et al. · Molecular Therapy · 44
PDF
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
2024 · Mathieu Ferrari, Matteo Righi, et al. · Nature Communications · 26
PDF
Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein–Protein Interaction
2024 · Ram Jha, Alexander Kinna, et al. · ACS Chemical Biology · 8
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR
2023 · Evangelia Kokalaki, Biao Ma, et al. · Molecular Therapy · 2
A Dual Targeting Car‐t Cell Approach for the Treatment of B Cell Malignancies
2017 · S. Thomas, V. Baldan, et al. · Hematological Oncology · 2
PDF
Antibody format matters: A comparative analysis of VHH and scFv domains reveals superior in vivo CAR T cell function with VHH domains
2026 · Alexander Kinna, Preeta Datta, et al. · Molecular Therapy · 1
Generation of a Highly Sensitive CD22 CAR
2019 · Evangelia K Kokalaki, Biao Ma, et al. · Blood · 1
A High Sensitivity aCD22 CAR Combined with aCD19 CAR to Generate Dual Targeting CAR T Cells for the Treatment of r/r B-ALL
2021 · Evangelia K Kokalaki, Biao Ma, et al. · Blood
Works count: 11
Citation count: 438
H-index: 5
I10-index: 4
Year
Topic
Type